Lenalidomide versus thalidomide in myeloma
Lenalidomide versus thalidomide in myeloma
Does the use of generics of imatinib for chronic myeloid leukaemia jeopardise patient safety?
Importance of oncology nurses' work and research to cancer care
Regorafenib shows early promise in colorectal candidates unable to undergo chemo
New agents extend progression-free survival in double refractory myeloma
Use of GA101 and Clb preferable to rituximab in elderly or unfit chronic lymphocytic leukaemia patients
Work and history of the Kidney Cancer Association
Impact of culture, sociology and psychology on cancer and the role of AORTIC
History and ongoing work of AORTIC
AORTIC and the benefits of coordination between different US NCI-designated cancer centres in Kenya
Role of AORTIC in dealing with rising cancer rates in Africa
ecancermedicalscience Editor's Choice for April 2014